Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Correspondence data for kappa and lambda free light chain analysis | Download Table
TECHNICALREVIEW
Following & Understanding Your Free Light Chain Test Results - YouTube
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Frontiers | Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
J Clin Med Res
Light Chain Deposition Disease | UNC Kidney Center
Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD